Colorectal Carcinoma

Oncology·MeSH: Colorectal Neoplasms

21 drugs in development·10 companies·18 clinical trials

Drug Pipeline by Phase

Phase 3(6)

Drug	Company
BET Bromodomain Inhibitor ZEN-3694	Merus N.V. (MRUS)
cetuximab	GH Research PLC (GHRS)
FOLFOX	KYNTRA BIO INC. (KYNB)
Fruquintinib	IGM Biosciences, Inc. (IGMS)
panitumumab	GH Research PLC (GHRS)
Tucatinib	PFIZER INC (PFE)

Phase 2(8)

Drug	Company
5 FU bolus	IGM Biosciences, Inc. (IGMS)
5 FU continuous	IGM Biosciences, Inc. (IGMS)
Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5	CG Oncology, Inc. (CGON)
FOLFOX regimen	KYNTRA BIO INC. (KYNB)
Immune checkpoint inhibitor	KYNTRA BIO INC. (KYNB)
Ivonescimab	IGM Biosciences, Inc. (IGMS)
Nogapendekin Alfa	CG Oncology, Inc. (CGON)
ot-101	Oncotelic Therapeutics, Inc. (OTLC)

Phase 1(4)

Drug	Company
Aminolevulinic Acid	ENANTA PHARMACEUTICALS INC (ENTA)
leucovorin	PFIZER INC (PFE)
Muzastotug	IGM Biosciences, Inc. (IGMS)
Photodynamic Therapy	ENANTA PHARMACEUTICALS INC (ENTA)

Preclinical(2)

Drug	Company
iv rhdnase i	Xenetic Biosciences, Inc. (XBIO)
VPS4A inhibitors (novel series)	Calithera Biosciences, Inc. (CALA)

Phase 4(1)

Drug	Company
Leucovorin Calcium	IGM Biosciences, Inc. (IGMS)

BioSniper tracks 21 drugs in development for Colorectal Carcinoma across 10 companies.

There are 18 clinical trials targeting Colorectal Carcinoma tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.